https://www.sciencedaily.com/news/health_medicine/mumps,_measles,_rubella/ Read the latest medical news on the mumps, measles and rubella viruses, including information on symptoms, vaccination and treatment. en-us Sun, 12 Apr 2026 03:15:17 EDT Sun, 12 Apr 2026 03:15:17 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/mumps,_measles,_rubella/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/02/260222092258.htm Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common allergens. Instead of targeting a specific virus or bacterium, the nasal spray vaccine supercharges the lungs’ own immune defenses, keeping them on high alert for months. In mice, it slashed viral levels, prevented severe illness, and even blocked allergic reactions. Mon, 23 Feb 2026 08:45:18 EST https://www.sciencedaily.com/releases/2026/02/260222092258.htm https://www.sciencedaily.com/releases/2026/02/260204114343.htm As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong protection against H5N1 in animal tests, outperforming traditional flu shots. Because it targets the nose and lungs, it may prevent infection at the earliest stage. Wed, 04 Feb 2026 11:43:43 EST https://www.sciencedaily.com/releases/2026/02/260204114343.htm https://www.sciencedaily.com/releases/2025/12/251203004721.htm A unique vaccine rollout in Wales gave researchers an accidental natural experiment that revealed a striking reduction in dementia among seniors who received the shingles vaccine. The protective effect held steady across multiple analyses and was even stronger in women. Evidence also suggests benefits for people who already have dementia, hinting at a therapeutic effect. Wed, 03 Dec 2025 10:22:27 EST https://www.sciencedaily.com/releases/2025/12/251203004721.htm https://www.sciencedaily.com/releases/2025/10/251027224837.htm Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer treatment outcomes. If confirmed, the discovery could lead to a universal cancer vaccine and transform oncology care. Tue, 28 Oct 2025 09:47:26 EDT https://www.sciencedaily.com/releases/2025/10/251027224837.htm https://www.sciencedaily.com/releases/2025/08/250827010734.htm Researchers propose that the U.S. could safely drop adult tetanus and diphtheria boosters, saving $1 billion annually, since childhood vaccinations provide decades of protection. Evidence from the U.K. shows that skipping boosters has not led to higher disease rates. Wed, 27 Aug 2025 11:16:28 EDT https://www.sciencedaily.com/releases/2025/08/250827010734.htm https://www.sciencedaily.com/releases/2025/05/250529124357.htm The global measles outbreak must trigger an urgent debate into whether a vaccine should be recommended earlier to better protect against the highly contagious disease during infancy, a new review states. Thu, 29 May 2025 12:43:57 EDT https://www.sciencedaily.com/releases/2025/05/250529124357.htm https://www.sciencedaily.com/releases/2025/05/250515145628.htm A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven't worked -- largely because HIV mutates rapidly and hides key parts of itself from the immune system. Now, a new study combining data from two separate phase 1 clinical trials shows that a targeted vaccine strategy can successfully activate early immune responses relevant to HIV, and, in one trial, further advance them -- a key step toward a long-sought goal in vaccine development. Thu, 15 May 2025 14:56:28 EDT https://www.sciencedaily.com/releases/2025/05/250515145628.htm https://www.sciencedaily.com/releases/2025/05/250512153403.htm An innovative outbreak detection program that tracks disease-causing viruses in wastewater identified the measles virus in Houston samples collected in early January 2025, before cases were reported. Mon, 12 May 2025 15:34:03 EDT https://www.sciencedaily.com/releases/2025/05/250512153403.htm https://www.sciencedaily.com/releases/2025/04/250414183623.htm Pediatric infectious diseases experts stress the importance of vaccination against measles, one of the most contagious viruses, which is once more spreading in the United States. Mon, 14 Apr 2025 18:36:23 EDT https://www.sciencedaily.com/releases/2025/04/250414183623.htm https://www.sciencedaily.com/releases/2025/04/250414124340.htm Like the dengue and Zika viruses, Oropouche virus causes a febrile illness. There are recent indications that infections during pregnancy can cause damage to unborn babies. Researchers have now determined that the virus is much more widespread in Latin America than previously assumed. Their study also suggests that climatic conditions have a significant influence on the virus's spread. Mon, 14 Apr 2025 12:43:40 EDT https://www.sciencedaily.com/releases/2025/04/250414124340.htm https://www.sciencedaily.com/releases/2025/04/250408121657.htm Researchers have shown that differences in the entire rotavirus genome -- not just its two surface proteins -- affect how well vaccines work, helping to explain why some strains are more likely to infect vaccinated individuals. Tue, 08 Apr 2025 12:16:57 EDT https://www.sciencedaily.com/releases/2025/04/250408121657.htm https://www.sciencedaily.com/releases/2025/04/250402200920.htm Organoids have revolutionized science and medicine, providing platforms for disease modeling, drug testing, and understanding developmental processes. While not exact replicas of human organs, they offer significant insights. Scientists now present a new organoid model that reveals details of the developing nervous system's response to viral infections, such as Rubella. This model could influence pharmaceutical testing, particularly benefiting drug safety for pregnant women. Wed, 02 Apr 2025 20:09:20 EDT https://www.sciencedaily.com/releases/2025/04/250402200920.htm https://www.sciencedaily.com/releases/2025/04/250402122149.htm A unique vaccination rollout in Wales offered researchers a natural experiment: some older adults qualified for the shingles vaccine, while others just missed the cutoff. The results were striking — those who got the shot had a 20% lower risk of developing dementia within seven years. This breakthrough hints that viruses lurking in the nervous system may contribute to dementia and that prevention could be simpler than anyone imagined. Wed, 02 Apr 2025 12:21:49 EDT https://www.sciencedaily.com/releases/2025/04/250402122149.htm https://www.sciencedaily.com/releases/2025/03/250325141538.htm This research comes as many mosquito-borne viruses are spreading rapidly. Tue, 25 Mar 2025 14:15:38 EDT https://www.sciencedaily.com/releases/2025/03/250325141538.htm https://www.sciencedaily.com/releases/2025/03/250319143643.htm A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, and people with HIV in particular, should therefore receive the second dose of the vaccine as recommended. Wed, 19 Mar 2025 14:36:43 EDT https://www.sciencedaily.com/releases/2025/03/250319143643.htm https://www.sciencedaily.com/releases/2025/03/250311122707.htm A more affordable, lower-risk polio vaccine is on the horizon, research has found. Tue, 11 Mar 2025 12:27:07 EDT https://www.sciencedaily.com/releases/2025/03/250311122707.htm https://www.sciencedaily.com/releases/2025/02/250224143249.htm This research comes as dengue-carrying mosquitoes expand their territory into new regions, including Southern California. Mon, 24 Feb 2025 14:32:49 EST https://www.sciencedaily.com/releases/2025/02/250224143249.htm https://www.sciencedaily.com/releases/2025/02/250220122507.htm Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect. Thu, 20 Feb 2025 12:25:07 EST https://www.sciencedaily.com/releases/2025/02/250220122507.htm https://www.sciencedaily.com/releases/2025/01/250116133323.htm Amid a global surge in measles cases, new research suggests that undernutrition may be exacerbating outbreaks in areas suffering from food insecurity. A study involving over 600 fully vaccinated children in South Africa found those who were undernourished had substantially lower levels of antibodies against measles. Thu, 16 Jan 2025 13:33:23 EST https://www.sciencedaily.com/releases/2025/01/250116133323.htm https://www.sciencedaily.com/releases/2024/12/241223135334.htm A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new health survey. Mon, 23 Dec 2024 13:53:34 EST https://www.sciencedaily.com/releases/2024/12/241223135334.htm https://www.sciencedaily.com/releases/2024/12/241219151655.htm Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them, scientists have shown. Thu, 19 Dec 2024 15:16:55 EST https://www.sciencedaily.com/releases/2024/12/241219151655.htm https://www.sciencedaily.com/releases/2024/12/241218132122.htm A live-attenuated vaccine under development is safe and 100% effective against Lassa virus in preclinical studies. Wed, 18 Dec 2024 13:21:22 EST https://www.sciencedaily.com/releases/2024/12/241218132122.htm https://www.sciencedaily.com/releases/2024/11/241113123430.htm An FDA-approved vaccine for smallpox and mpox is effective but causes side effects. The other requires multiple doses. An experimental single-dose vaccine uses the horsepox virus to harness the benefits of both strategies. Wed, 13 Nov 2024 12:34:30 EST https://www.sciencedaily.com/releases/2024/11/241113123430.htm https://www.sciencedaily.com/releases/2024/10/241008201425.htm Driven in part by climate change, epidemics from mosquito-spread viruses are occurring with increasing frequency. Yet few among the American public are worried about getting West Nile or dengue virus in the coming months, and knowledge about how to protect oneself from these illnesses is spotty, a new survey finds. Tue, 08 Oct 2024 20:14:25 EDT https://www.sciencedaily.com/releases/2024/10/241008201425.htm https://www.sciencedaily.com/releases/2024/10/241007115102.htm Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults. Mon, 07 Oct 2024 11:51:02 EDT https://www.sciencedaily.com/releases/2024/10/241007115102.htm https://www.sciencedaily.com/releases/2024/09/240912135656.htm A promising Lassa fever vaccine shows potential to prevent severe disease and death in animals. Thu, 12 Sep 2024 13:56:56 EDT https://www.sciencedaily.com/releases/2024/09/240912135656.htm https://www.sciencedaily.com/releases/2024/09/240904130825.htm The most frequently used mpox vaccine provides partial immunity to the disease but isn't always able to prevent severe symptoms or disease transmission. A new vaccine candidate from Moderna, mRNA-1769, more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed modified vaccinia Ankara (MVA) vaccine. Wed, 04 Sep 2024 13:08:25 EDT https://www.sciencedaily.com/releases/2024/09/240904130825.htm https://www.sciencedaily.com/releases/2024/08/240821124236.htm A new study that examined health data on 18 million people reveals higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Wed, 21 Aug 2024 12:42:36 EDT https://www.sciencedaily.com/releases/2024/08/240821124236.htm https://www.sciencedaily.com/releases/2024/08/240814185758.htm Recent trials of an experimental malaria vaccine in healthy Malian adults found that all three tested regimens were safe. One of the trials enrolled 300 healthy women ages 18 to 38 years who anticipated becoming pregnant soon after immunization. That trial began with drug treatment to remove malaria parasites, followed by three injections spaced over a month of either saline placebo or the investigational vaccine at one of two dosages. Wed, 14 Aug 2024 18:57:58 EDT https://www.sciencedaily.com/releases/2024/08/240814185758.htm https://www.sciencedaily.com/releases/2024/08/240809135948.htm A new, two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and effective in pigs, researchers report. Fri, 09 Aug 2024 13:59:48 EDT https://www.sciencedaily.com/releases/2024/08/240809135948.htm https://www.sciencedaily.com/releases/2024/07/240731170756.htm A nasal COVID-19 vaccine blocks transmission of the virus, according to an animal study. The findings suggest that vaccines delivered directly to the nose or mouth could play a critical role in containing the spread of respiratory infections. Wed, 31 Jul 2024 17:07:56 EDT https://www.sciencedaily.com/releases/2024/07/240731170756.htm https://www.sciencedaily.com/releases/2024/07/240729104219.htm SARS-CoV-2, the virus responsible for COVID-19, is widespread among wildlife species, according to new research. The virus was detected in six common backyard species, and antibodies indicating prior exposure to the virus were found in five species, with rates of exposure ranging from 40 to 60 percent depending on the species. Mon, 29 Jul 2024 10:42:19 EDT https://www.sciencedaily.com/releases/2024/07/240729104219.htm https://www.sciencedaily.com/releases/2024/07/240725154643.htm Over the last century, a once-deadly mosquito-borne virus has evolved so that it no longer sickens humans. New research shows that changes in the virus's ability to target human cells paralleled the decline in illness and death. The findings offer important lessons in virology that may help guide better preparedness for future outbreaks of other viral diseases. Thu, 25 Jul 2024 15:46:43 EDT https://www.sciencedaily.com/releases/2024/07/240725154643.htm https://www.sciencedaily.com/releases/2024/07/240719123816.htm New research reveals a promising approach to developing a universal influenza vaccine -- a so-called 'one and done' vaccine that confers lifetime immunity against an evolving virus. The study tested a vaccine platform against the virus considered most likely to trigger the next pandemic. Fri, 19 Jul 2024 12:38:16 EDT https://www.sciencedaily.com/releases/2024/07/240719123816.htm https://www.sciencedaily.com/releases/2024/07/240717204059.htm The risk of long COVID has declined over the course of the pandemic, although it remains a persistent threat. Researchers identified vaccination as a primary factor in reducing the risk of long COVID. Wed, 17 Jul 2024 20:40:59 EDT https://www.sciencedaily.com/releases/2024/07/240717204059.htm https://www.sciencedaily.com/releases/2024/06/240627172004.htm What happens when measles virus meets a human cell? The viral machinery unfolds in just the right way to reveal key pieces that let it fuse itself into the host cell membrane. Thu, 27 Jun 2024 17:20:04 EDT https://www.sciencedaily.com/releases/2024/06/240627172004.htm https://www.sciencedaily.com/releases/2024/05/240529144253.htm An international team developed a new model, based on a case study of Nigeria, that may help public health officials accelerate the introduction of rubella vaccination in countries that have yet to do so. Wed, 29 May 2024 14:42:53 EDT https://www.sciencedaily.com/releases/2024/05/240529144253.htm https://www.sciencedaily.com/releases/2024/05/240522130506.htm Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1 diabetes during the COVID-19 pandemic. Wed, 22 May 2024 13:05:06 EDT https://www.sciencedaily.com/releases/2024/05/240522130506.htm https://www.sciencedaily.com/releases/2024/05/240517111457.htm An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial. Fri, 17 May 2024 11:14:57 EDT https://www.sciencedaily.com/releases/2024/05/240517111457.htm https://www.sciencedaily.com/releases/2024/05/240513105151.htm Birth by C-section more than doubles odds of measles vaccine failure. Researchers say it is vital that children born by caesarean section receive two doses of the measles vaccine for robust protection against the disease. Mon, 13 May 2024 10:51:51 EDT https://www.sciencedaily.com/releases/2024/05/240513105151.htm https://www.sciencedaily.com/releases/2024/05/240506131555.htm Researchers have found a way to enhance and extend LN expansion, and study how this phenomenon affects both the immune system and efficacy of vaccinations against tumors. While the oversized LNs maintained a normal tissue organization, they displayed altered mechanical features and hosted higher numbers of various immune cell types that commonly are involved in immune responses against pathogens and cancers. Importantly, 'jump-starting' lymph node expansion prior to administering a traditional vaccine against a melanoma-specific model antigen led to more effective and sustained anti-tumor responses in mice. Mon, 06 May 2024 13:15:55 EDT https://www.sciencedaily.com/releases/2024/05/240506131555.htm https://www.sciencedaily.com/releases/2024/04/240429201917.htm The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that painlessly penetrate the skin and deliver the vaccine, or by conventional injection with a needle and syringe. Mon, 29 Apr 2024 20:19:17 EDT https://www.sciencedaily.com/releases/2024/04/240429201917.htm https://www.sciencedaily.com/releases/2024/04/240429165830.htm A new study shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations. Mon, 29 Apr 2024 16:58:30 EDT https://www.sciencedaily.com/releases/2024/04/240429165830.htm https://www.sciencedaily.com/releases/2024/04/240417131027.htm Adults with congenital heart defects were more likely to experience an abnormal, irregular heartbeat, finds a new study. Wed, 17 Apr 2024 13:10:27 EDT https://www.sciencedaily.com/releases/2024/04/240417131027.htm https://www.sciencedaily.com/releases/2024/04/240415163733.htm Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised. Mon, 15 Apr 2024 16:37:33 EDT https://www.sciencedaily.com/releases/2024/04/240415163733.htm https://www.sciencedaily.com/releases/2024/04/240401190423.htm Researchers have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses. The groundbreaking trivalent vaccine has shown complete protection with no trace of virus in the lungs, marking a significant step toward a universal vaccine for coronaviruses. Mon, 01 Apr 2024 19:04:23 EDT https://www.sciencedaily.com/releases/2024/04/240401190423.htm https://www.sciencedaily.com/releases/2024/03/240326170114.htm Researchers have come up with a new, more accurate method for detecting in ticks the emerging Powassan virus, which can cause life-threatening neuroinvasive disease, including encephalitis and meningitis. Tue, 26 Mar 2024 17:01:14 EDT https://www.sciencedaily.com/releases/2024/03/240326170114.htm https://www.sciencedaily.com/releases/2024/03/240314122054.htm Antibody responses to new SARS-CoV-2 variant infections and vaccinations are powerfully shaped by prior exposures to earlier SARS-CoV-2 vaccines, according to a new study. Thu, 14 Mar 2024 12:20:54 EDT https://www.sciencedaily.com/releases/2024/03/240314122054.htm https://www.sciencedaily.com/releases/2024/03/240308123306.htm Scientists have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumor growth, while sparing healthy cells. Fri, 08 Mar 2024 12:33:06 EST https://www.sciencedaily.com/releases/2024/03/240308123306.htm https://www.sciencedaily.com/releases/2024/03/240304135729.htm A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research. Mon, 04 Mar 2024 13:57:29 EST https://www.sciencedaily.com/releases/2024/03/240304135729.htm https://www.sciencedaily.com/releases/2024/02/240220144618.htm Researchers found that PD-1-enhanced DNA vaccination can induce sustained virus-specific CD8+ T cell immunity in an AIDS monkey model. The vaccinated monkeys remained free of AIDS for six years and achieved virologic control without the need for combination antiretroviral therapy (cART), a treatment used to suppress viral replication in individuals living with human immunodeficiency virus (HIV). The study also found that polyfunctional and broadly reactive effector-memory virus-specific T cells were maintained in the protected experimental macaques for over six years. The findings provide supporting evidence that the PD-1-enhanced DNA vaccine strategy holds promise as a third-generation DNA vaccine for AIDS prevention and immunotherapy. Tue, 20 Feb 2024 14:46:18 EST https://www.sciencedaily.com/releases/2024/02/240220144618.htm https://www.sciencedaily.com/releases/2024/02/240208122036.htm An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of pregestational diabetes-induced congenital heart disease found in mice and humans. The findings also showed that endoplasmic reticulum (ER) stress and lipid imbalance are critical factors contributing to these disorders, which could be ameliorated with exposure to omega-3s. Thu, 08 Feb 2024 12:20:36 EST https://www.sciencedaily.com/releases/2024/02/240208122036.htm https://www.sciencedaily.com/releases/2024/01/240130133628.htm Using a DNA-based delivery particle, researchers created a vaccine that can induce a strong antibody response against SARS-CoV-2. Tue, 30 Jan 2024 13:36:28 EST https://www.sciencedaily.com/releases/2024/01/240130133628.htm https://www.sciencedaily.com/releases/2024/01/240117183631.htm Imagine a vaccine that speeds up the production of antibodies against SARS-CoV-2, the virus that spreads COVID-19. A research team has developed such a vaccine by using preexisting immunity to a separate virus (the influenza virus) to help kickstart the process of making antibodies against SARS-CoV-2. Wed, 17 Jan 2024 18:36:31 EST https://www.sciencedaily.com/releases/2024/01/240117183631.htm https://www.sciencedaily.com/releases/2024/01/240111112246.htm A new study suggests that once developed, a universal vaccine in advance of the next coronavirus epidemic/pandemic can save up to 7 million hospitalizations and 2 million deaths even when it is the only intervention being implemented and its efficacy is as low as 10 percent. Thu, 11 Jan 2024 11:22:46 EST https://www.sciencedaily.com/releases/2024/01/240111112246.htm https://www.sciencedaily.com/releases/2023/12/231221162235.htm Researchers mapped how the measles virus mutated and spread in the brain of a person who succumbed to a rare, lethal brain disease. New cases of this disease, which is a complication of the measles virus, may occur as measles reemerges among the unvaccinated, say researchers. Thu, 21 Dec 2023 16:22:35 EST https://www.sciencedaily.com/releases/2023/12/231221162235.htm https://www.sciencedaily.com/releases/2023/12/231201123720.htm A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus. Fri, 01 Dec 2023 12:37:20 EST https://www.sciencedaily.com/releases/2023/12/231201123720.htm https://www.sciencedaily.com/releases/2023/11/231108115043.htm The most effective way to prevent cervical cancer is to give HPV vaccines to both boys and girls, reports a collaborative study. Beside personal immunity, such use of the vaccine also induces a herd immunity that will help to eradicate the carcinogenic virus types more quickly. Wed, 08 Nov 2023 11:50:43 EST https://www.sciencedaily.com/releases/2023/11/231108115043.htm https://www.sciencedaily.com/releases/2023/10/231002170824.htm Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests. Mon, 02 Oct 2023 17:08:24 EDT https://www.sciencedaily.com/releases/2023/10/231002170824.htm https://www.sciencedaily.com/releases/2023/08/230816170628.htm Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer's disease, according to new research. Wed, 16 Aug 2023 17:06:28 EDT https://www.sciencedaily.com/releases/2023/08/230816170628.htm